Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents
Document/Exhibit Description Pages Size
1: 10-K Form 10-K for Fiscal Year Ending 12/31/2013 HTML 1.30M
2: EX-4.8 Instrument Defining the Rights of Security Holders HTML 46K
3: EX-10.22 Material Contract HTML 68K
4: EX-10.23 Material Contract HTML 53K
5: EX-10.24 Material Contract HTML 53K
6: EX-10.25 Material Contract HTML 52K
7: EX-10.29 Material Contract HTML 24K
8: EX-10.30 Material Contract HTML 24K
9: EX-10.31 Material Contract HTML 24K
10: EX-10.32 Material Contract HTML 26K
11: EX-23.1 Consent of Experts or Counsel HTML 22K
12: EX-31.1 Certification -- §302 - SOA'02 HTML 26K
13: EX-31.2 Certification -- §302 - SOA'02 HTML 26K
14: EX-32.1 Certification -- §906 - SOA'02 HTML 22K
15: EX-32.2 Certification -- §906 - SOA'02 HTML 22K
54: R1 Document and Entity Information HTML 49K
44: R2 Consolidated Balance Sheets HTML 95K
52: R3 Consolidated Balance Sheets (Parenthetical) HTML 48K
56: R4 Consolidated Statements of Operations HTML 70K
72: R5 Consolidated Statements of Stockholders' Equity HTML 71K
46: R6 Consolidated Statements of Cash Flows HTML 116K
51: R7 Nature of Business HTML 28K
41: R8 Summary of Significant Accounting Policies HTML 71K
33: R9 Receivables HTML 26K
73: R10 Prepaid and Other Assets HTML 23K
58: R11 Short-term Investments HTML 27K
57: R12 Equipment and Furnishings HTML 31K
62: R13 Accrued Expenses and Other Current Liabilities HTML 31K
63: R14 Warrant Liabilities HTML 36K
61: R15 Commitments and Contingencies HTML 51K
64: R16 Equity Transactions HTML 33K
53: R17 Investments in ADVENTRX Pharmaceuticals HTML 26K
55: R18 Stock Options and Warrants HTML 221K
60: R19 Sale of Assets HTML 23K
77: R20 Stockholder Protection Rights Plan HTML 25K
67: R21 Income Taxes HTML 58K
48: R22 Quarterly Financial Data (Unaudited) HTML 48K
59: R23 Subsequent Events HTML 59K
50: R24 Schedule Ii - Valuation and Qualifying Accounts HTML 40K
27: R25 Summary of Significant Accounting Policies HTML 124K
(Policies)
68: R26 Summary of Significant Accounting Policies HTML 47K
(Tables)
74: R27 Equipment and Furnishings (Tables) HTML 29K
37: R28 Accrued Expenses and Other Current Liabilities HTML 30K
(Tables)
36: R29 Warrant Liabilities (Tables) HTML 34K
39: R30 Commitments and Contingencies (Tables) HTML 45K
40: R31 Stock Options and Warrants (Tables) HTML 218K
42: R32 Income Taxes (Tables) HTML 53K
26: R33 Quarterly Financial Data (Unaudited) (Tables) HTML 46K
65: R34 Subsequent Events (Tables) HTML 58K
47: R35 Nature of Business (Details) HTML 40K
49: R36 Summary of Significant Accounting Policies HTML 67K
(Details)
30: R37 Receivables (Details) HTML 23K
76: R38 Prepaid and Other Assets (Details) HTML 23K
22: R39 Short-term Investments (Details) HTML 26K
43: R40 Equipment and Furnishings (Details) HTML 34K
71: R41 Accrued Expenses and Other Current Liabilities HTML 35K
(Details)
29: R42 Warrant Liabilities (Details) HTML 41K
35: R43 Commitments and Contingencies (Details) HTML 83K
38: R44 Equity Transactions (Details) HTML 49K
45: R45 Investments in ADVENTRX Pharmaceuticals (Details) HTML 32K
25: R46 Stock Options and Warrants (Details) HTML 304K
32: R47 Sale of Assets (Details) HTML 24K
23: R48 Stockholder Protection Rights Plan (Details) HTML 33K
70: R49 Income Taxes (Details) HTML 96K
28: R50 Quarterly Financial Data (Unaudited) (Details) HTML 37K
66: R51 Subsequent Events (Details) HTML 87K
31: R52 Schedule Ii - Valuation and Qualifying Accounts HTML 32K
(Details)
75: XML IDEA XML File -- Filing Summary XML 100K
24: EXCEL IDEA Workbook of Financial Reports XLSX 171K
34: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 1.26M
16: EX-101.INS XBRL Instance -- cytr-20131231 XML 1.91M
18: EX-101.CAL XBRL Calculations -- cytr-20131231_cal XML 190K
19: EX-101.DEF XBRL Definitions -- cytr-20131231_def XML 469K
20: EX-101.LAB XBRL Labels -- cytr-20131231_lab XML 1.57M
21: EX-101.PRE XBRL Presentations -- cytr-20131231_pre XML 873K
17: EX-101.SCH XBRL Schema -- cytr-20131231 XSD 162K
69: ZIP XBRL Zipped Folder -- 0000799698-14-000004-xbrl Zip 166K
Filing Submission 0000799698-14-000004 – SGML Text
Original SGML Text submitted by: | LadRx Corp. [ formerly Cytrx Corp. ] |
---|
To view the SGML, please refresh this page.
↑Top
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help —
Thu., Mar. 28, 6:35:59.1pm ET